EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription

PLoS Pathogens

Volumn 7, Issue 11, 2011, Pages

  Tsai, Kevin ^a,b   Thikmyanova, Nadezhda ^a   Wojcechowskyj, Jason A ^b   Delecluse, Henri Jacques ^c   Lieberman, Paul M ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BNRF1 PROTEIN; DAXX PROTEIN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL RESISTANCE; ARTICLE; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPSTEIN BARR VIRUS; GENE MAPPING; GENETIC TRANSCRIPTION; LATENT VIRUS INFECTION; LYMPHOBLASTOID CELL LINE; NONHUMAN; PROTEIN DOMAIN; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE; CELL NUCLEUS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA HELICASES; EPSTEIN-BARR VIRUS INFECTIONS; HEK293 CELLS; HERPESVIRUS 4, HUMAN; HUMANS; NUCLEAR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRUS LATENCY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 81755166682     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002376     Document Type: Article

References (64)

1. Cohen JI, (2000) Epstein-Barr virus infection. N Engl J Med 343: 481-492.
2. Rickinson AB, Kieff E, (2007) Epstein-Barr Virus. In: Fields BN, Knipe DM, Howley PM, editors. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 2 v. (xix, 3091, 3086 p.) p.
3. Young LS, Rickinson AB, (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4: 757-768.
4. Kieff E, (2007) Epstein-Barr Virus and its replication. In: Fields BN, Knipe DM, Howley PM, editors. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 2 v. (xix, 3091, 3086 p.) p.
5. Gottschalk S, Rooney CM, Heslop HE, (2005) Post-Transplant Lymphoproliferative Disorders. Annu Rev Med 56: 29-44.
6. Bernardi R, Pandolfi PP, (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8: 1006-1016.
7. Everett RD, Chelbi-Alix MK, (2007) PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89: 819-830.
8. Chelbi-Alix MK, Pelicano L, Quignon F, Koken MH, Venturini L, et al. (1995) Induction of the PML protein by interferons in normal and APL cells. Leukemia 9: 2027-2033.
9. Grotzinger T, Jensen K, Will H, (1996) The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J Biol Chem 271: 25253-25260.
10. Lavau C, Marchio A, Fagioli M, Jansen J, Falini B, et al. (1995) The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11: 871-876.
11. Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, de The H, (1998) Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol 72: 1043-1051.
12. Ishov AM, Maul GG, (1996) The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol 134: 815-826.
13. Korioth F, Maul GG, Plachter B, Stamminger T, Frey J, (1996) The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res 229: 155-158.
14. Hensel GM, Meyer HH, Buchmann I, Pommerehne D, Schmolke S, et al. (1996) Intracellular localization and expression of the human cytomegalovirus matrix phosphoprotein pp71 (ppUL82): evidence for its translocation into the nucleus. J Gen Virol 77 (Pt 12): 3087-3097.
15. Zhong S, Salomoni P, Pandolfi PP, (2000) The transcriptional role of PML and the nuclear body. Nat Cell Biol 2: E85-90.
16. Lehembre F, Muller S, Pandolfi PP, Dejean A, (2001) Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Oncogene 20: 1-9.
17. Emelyanov AV, Kovac CR, Sepulveda MA, Birshtein BK, (2002) The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells. J Biol Chem 277: 11156-11164.
18. Li R, Pei H, Watson DK, Papas TS, (2000) EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes. Oncogene 19: 745-753.
19. Michaelson JS, Leder P, (2003) RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX. J Cell Sci 116: 345-352.
20. Li H, Leo C, Zhu J, Wu X, O'Neil J, et al. (2000) Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol 20: 1784-1796.
21. Hollenbach AD, McPherson CJ, Mientjes EJ, Iyengar R, Grosveld G, (2002) Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J Cell Sci 115: 3319-3330.
22. Michaelson JS, Bader D, Kuo F, Kozak C, Leder P, (1999) Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development. Genes Dev 13: 1918-1923.
23. Muromoto R, Sugiyama K, Takachi A, Imoto S, Sato N, et al. (2004) Physical and functional interactions between Daxx and DNA methyltransferase 1-associated protein, DMAP1. J Immunol 172: 2985-2993.
24. Saffert RT, Kalejta RF, (2006) Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80: 3863-3871.
25. Woodhall DL, Groves IJ, Reeves MB, Wilkinson G, Sinclair JH, (2006) Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J Biol Chem 281: 37652-37660.
26. Xue Y, Gibbons R, Yan Z, Yang D, McDowell TL, et al. (2003) The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc Natl Acad Sci U S A 100: 10635-10640.
27. Ishov AM, Vladimirova OV, Maul GG, (2004) Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX. J Cell Sci 117: 3807-3820.
28. Tavalai N, Papior P, Rechter S, Stamminger T, (2008) Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol 82: 126-137.
29. Cantrell SR, Bresnahan WA, (2006) Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J Virol 80: 6188-6191.
30. Lukashchuk V, McFarlane S, Everett RD, Preston CM, (2008) Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J Virol 82: 12543-12554.
31. Lukashchuk V, Everett RD, (2010) Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx. J Virol 84: 4026-4040.
32. Smibert CA, Popova B, Xiao P, Capone JP, Smiley JR, (1994) Herpes simplex virus VP16 forms a complex with the virion host shutoff protein vhs. J Virol 68: 2339-2346.
33. Boutell C, Sadis S, Everett RD, (2002) Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol 76: 841-850.
34. Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, et al. (1998) The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J Virol 72: 6581-6591.
35. Maul GG, Guldner HH, Spivack JG, (1993) Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J Gen Virol 74 (Pt 12): 2679-2690.
36. Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, et al. (2006) PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol 80: 7995-8005.
37. Preston CM, Nicholl MJ, (1997) Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis. J Virol 71: 7807-7813.
38. Stow EC, Stow ND, (1989) Complementation of a herpes simplex virus type 1 Vmw110 deletion mutant by human cytomegalovirus. J Gen Virol 70 (Pt 3): 695-704.
39. Bell P, Lieberman PM, Maul GG, (2000) Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol 74: 11800-11810.
40. Adamson AL, Kenney S, (2001) Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol 75: 2388-2399.
41. Sivachandran N, Cao JY, Frappier L, (2010) Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies. J Virol 84: 11113-11123.
42. Ling PD, Peng RS, Nakajima A, Yu JH, Tan J, et al. (2005) Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. EMBO J 24: 3565-3575.
43. Johannsen E, Luftig M, Chase MR, Weicksel S, Cahir-McFarland E, et al. (2004) Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci U S A 101: 16286-16291.
44. Feederle R, Neuhierl B, Baldwin G, Bannert H, Hub B, et al. (2006) Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes. J Virol 80: 9435-9443.
45. Gaspar M, Gill MB, Losing JB, May JS, Stevenson PG, (2008) Multiple functions for ORF75c in murid herpesvirus-4 infection. PLoS One 3: e2781.
46. Ling PD, Tan J, Sewatanon J, Peng R, (2008) Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J Virol 82: 8000-8012.
47. Lindsay CR, Morozov VM, Ishov AM, (2008) PML NBs (ND10) and Daxx: from nuclear structure to protein function. Front Biosci 13: 7132-7142.
48. Kraus RJ, Perrigoue JG, Mertz JE, (2003) ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus. J Virol 77: 199-207.
49. Ellis AL, Wang Z, Yu X, Mertz JE, (2010) Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner. J Virol 84: 6139-6152.
50. Yu X, Wang Z, Mertz JE, (2007) ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus. PLoS Pathog 3: e194.
51. Bieniasz PD, (2007) An intrinsic host defense against HIV-1 integration? J Clin Invest 117: 302-304.
52. Bieniasz PD, (2004) Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 5: 1109-1115.
53. Michaelson JS, (2000) The Daxx enigma. Apoptosis 5: 217-220.
54. Hofmann H, Sindre H, Stamminger T, (2002) Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx. J Virol 76: 5769-5783.
55. Kolb G, Kristie TM, (2008) Association of the cellular coactivator HCF-1 with the Golgi apparatus in sensory neurons. J Virol 82: 9555-9563.
56. Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD, (2010) Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci U S A 107: 14075-14080.
57. Law MJ, Lower KM, Voon HP, Hughes JR, Garrick D, et al. (2010) ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell 143: 367-378.
58. Drane P, Ouararhni K, Depaux A, Shuaib M, Hamiche A, (2010) The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev 24: 1253-1265.
59. Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, et al. (2010) Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140: 678-691.
60. Loyola A, Almouzni G, (2007) Marking histone H3 variants: how, when and why? Trends Biochem Sci 32: 425-433.
61. Placek BJ, Huang J, Kent JR, Dorsey J, Rice L, et al. (2009) The histone variant H3.3 regulates gene expression during lytic infection with herpes simplex virus type 1. J Virol 83: 1416-1421.
62. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W, (1998) Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95: 8245-8250.
63. Busse C, Feederle R, Schnolzer M, Behrends U, Mautner J, et al. (2009) Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding. J Virol 84: 1139-1147.
64. Shanbhag NM, Rafalska-Metcalf IU, Balane-Bolivar C, Janicki SM, Greenberg RA, (2010) ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks. Cell 141: 970-981.